Table 3.
TXA group | Control group | P-value | |
---|---|---|---|
N = 32 | N = 64 | ||
Patients requiring ABT | 4 (12.5%) | 20 (31.3%) | 0.046 |
Patients with DVT | 3 (9.4%) | 5 (7.8%) | 0.794 |
Data given as number (percentage)
TXA tranexamic acid, ABT allogeneic blood transfusion
TXA group | Control group | P-value | |
---|---|---|---|
N = 32 | N = 64 | ||
Patients requiring ABT | 4 (12.5%) | 20 (31.3%) | 0.046 |
Patients with DVT | 3 (9.4%) | 5 (7.8%) | 0.794 |
Data given as number (percentage)
TXA tranexamic acid, ABT allogeneic blood transfusion